New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 4.7 (67 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.98 Min. order: 1 piece ★★★★★ 4.7 (278 reviews) Sold : Login>>
Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide US$ 22.60 Min. order: 1 piece ★★★★★ 4.8 (242 reviews) Sold : Login>>
Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits US$ 27.47 Min. order: 1 piece ★★★★★ 4.6 (202 reviews) Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 4.6 (180 reviews) Sold : Login>>